FDA's Oversight of the Promotion of Drugs for Off-Label Uses

The Government Accountability Office, GAO, which you may be familiar with, is the investigative arm of Congress and most of our work comes at the request of members of Congress. In July of last year we issued a report on the FDA’s oversight of the promotion of drugs for off-label uses. The report originated as a request from Senator Grassley, a Senator from Iowa who is very interested in FDA issues, and who was then the Chair of the Senate Finance Committee.

Announcements

 

The Albany Law Journal of Science & Technology's 20th Anniversary Symposium on Assisted Reproductive Technology will be taking place on October 28, 2010 commencing at 1:00pm !

For more information email Katherine Alexander (kalexander@albanylaw.edu) 

 

---

 

The Journal of Science & Technology is pleased to announce that it has recently been ranked eighth in the nation in a recent ranking of student edited intellectual property law journals. The rankings were conducted by Patentlyo.com, a leading law patent blog. The rankings are based on information gathered by the Washington & Lee Law Library, as well the frequency with which the journal is cited by court cases and other publications.

 

---

The Journal of Science & Technology is proud to announce that Theresa Stadheim, author of "Rambus, N-Data, and the FTC: Creating Efficient Incentives in Patent Holders and Optimizing Consumer Welfare in Standardsetting Organizations" (see 19 ALB. L.J. SCI. & TECH. 483 (2009) ), has won the 2009-2010 ABA Student Writing Competition.  Congratulations Theresa!

---

Congratulations and a big warm welcome to the Journal's newly elected 2010-2011 executive board!!

 

---

We have recently made the switch to paperless subediting.  Although this is a new process for us, the transition was a great success!